Global Real‑World Data Market Projected to Reach $7.31 B by 2035

A new report forecasts that the worldwide Real‑World Data (RWD) market will expand from $19.2 billion in 2025 to $73.1 billion by 2035, representing a compound annual growth rate of 14.3 %. The surge is driven by pharmaceutical and biotechnology firms seeking to streamline drug development, reduce costs, and improve trial design through patient‑level data from electronic health records, claims, registries, wearables and patient‑generated health data. Regulatory authorities are also encouraging the use of real‑world evidence (RWE) for post‑approval safety monitoring and market access decisions. Advanced analytics powered by artificial intelligence, machine learning and natural language processing are accelerating the extraction of insights from large, complex datasets, especially in oncology, rare diseases and chronic conditions. Regional initiatives to build digital‑health infrastructure and data‑sharing partnerships are further expanding market opportunities. Leading companies cited include IQVIA Holding Inc., IBM Corporation, Palantir Technologies Inc., Flatiron Health and Cerner Corporation.